Biosimilar Newsletter Archive

31. 03.20.25 -- Comparison Of WFI Production Methods 3/20/2025
    03/20/25 Biosimilar Development Newsletter
32. 03.13.25 -- Optimize Your High Concentration Biologic Production Process 3/13/2025

    03/13/25 Biosimilar Development Newsletter

33. 03.13.25 -- Emerging Trends In mAbs Manufacturing 3/13/2025
    03/13/25 Biosimilar Development Newsletter
34. 03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars 3/6/2025
    03/06/25 Biosimilar Development Newsletter
35. 02.27.25 -- A New Approach For Minimizing Human Errors In Biopharmaceuticals 2/27/2025
    02/27/25 Biosimilar Development Newsletter
36. 02.20.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/20/2025
    02/20/25 Biosimilar Development Newsletter
37. 02.13.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/13/2025
    02/13/25 Biosimilar Development Newsletter
38. 02.06.25 -- Developing ADCs? A Refresher On HPAPI Occupational Health Risk Mitigation 2/6/2025
    02/06/25 Biosimilar Development Newsletter
39. 01.30.25 -- New Regulatory Survey Findings: Biotech Market Access Challenges 1/30/2025
    01/30/25 Biosimilar Development Newsletter
40. 01.23.25 -- How To Establish A Win-Win Relationship With Your CDMO 1/23/2025
    01/23/25 Biosimilar Development Newsletter